The Progestin Medroxyprogesterone Acetate Affects HIV-1 Production in Human Lymphoid Tissue Explants in a Dose-Dependent and Glucocorticoid-like Fashion
The association between the use of the injectable contraceptive depot medroxyprogesterone acetate and HIV-1 susceptibility has been addressed mainly in respect to the changes occurring in the female genital mucosa and blood. However, one of the main sites of HIV-1 pathogenesis is lymphoid organs. To...
Guardado en:
Autores principales: | Christophe Vanpouille, Gökçe Günaydın, Mattias Jangard, Mario Clerici, Leonid Margolis, Kristina Broliden, Andrea Introini |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
MDPI AG
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/fbd963782d164fef985f0e60cd7ea207 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
PGRMC1 Promotes Progestin-Dependent Proliferation of Breast Cancer Cells by Binding Prohibitins Resulting in Activation of ERα Signaling
por: Yingxue Bai, et al.
Publicado: (2021) -
IMMUNOREGULATION OF BLOOD SERUM ESTRADIOL AND PROGESTERONE LEVELS IN POSTMENOPAUSAL WOMEN
por: A. N. Glushkov, et al.
Publicado: (2019) -
Resilient and Accelerated Scale-Up of Subcutaneously Administered Depot–Medroxyprogesterone Acetate in Nigeria (RASuDiN): A Mid-Line Study in COVID-19 Era
por: Osinowo K, et al.
Publicado: (2021) -
Off-label use of hormones as an antiaging strategy: a review
por: Samaras N, et al.
Publicado: (2014) -
Glutathione Transferases as Efficient Ketosteroid Isomerases
por: Bengt Mannervik, et al.
Publicado: (2021)